(Q34308953)

1 August 2017

Chronic hepatitis C and superimposed nonalcoholic fatty liver disease (English)

1 reference

metabolic dysfunction–associated steatotic liver disease

1 August 2017

0 references

1 reference

1 reference

1 reference

1 reference

Ong JP

1

1 reference

1 August 2017

Younossi ZM

2

1 reference

1 August 2017

Speer C

3

1 reference

1 August 2017

Olano A

4

1 reference

1 August 2017

Gramlich T

5

1 reference

1 August 2017

Boparai N

6

1 reference

1 August 2017

1 August 2001

1 reference

1 August 2017

1 reference

1 August 2017

21

1 reference

1 August 2017

266-271

1 reference

1 August 2017

4

1 reference

Hepatitis C: an update on the silent epidemic

1 August 2017

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0676.2001.021004266.X

Pathogenesis, natural history, treatment, and prevention of hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0676.2001.021004266.X

Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0676.2001.021004266.X

The natural course of chronic hepatitis C: a comparison between patients with genotypes 1 and 2 hepatitis C viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0676.2001.021004266.X

The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0676.2001.021004266.X

Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0676.2001.021004266.X

Histological grading and staging of chronic hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0676.2001.021004266.X

Diabetes mellitus as a risk factor of liver cirrhosis in patients with chronic hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0676.2001.021004266.X

Body composition and hepatic steatosis as precursors for fibrotic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0676.2001.021004266.X

inferred from DOI database lookup

7 January 2021

based on heuristic

The long-term pathological evolution of chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0676.2001.021004266.X

inferred from DOI database lookup

7 January 2021

based on heuristic

Fibrosis in chronic hepatitis C correlates significantly with body mass index and steatosis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0676.2001.021004266.X

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1034/J.1600-0676.2001.021004266.X

1 reference

1 August 2017

1 reference